Unexpected findings with apomorphine and their possible consequences.
D000284:Administration, Oral; D000978:Antiparkinson Agents; D001058:Apomorphine / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D055598:Chemical Phenomena; D002621:Chemistry; D004305:Dose-Response Relationship, Drug; D004336:Drug Antagonism; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D006801:Humans; D007279:Injections, Subcutaneous; D007980:Levodopa / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D009069:Movement Disorders / Q000139:chemically induced / Q000517:prevention & control; D010300:Parkinson Disease / Q000188:drug therapy*; D013329:Structure-Activity Relationship; D014511:Uremia / Q000139:chemically induced
D000978:Antiparkinson Agents; D007980:Levodopa; D001058:Apomorphine